Our Approach To Chronic Myelogenous Leukemia in Adults

What Sets Us Apart

Chronic myelogenous leukemia is a slow-growing cancer that starts in the bone marrow, the spongy tissue inside bones, and spreads to the blood. People with this condition have a translocation, or the movement of part of one gene on one chromosome to another. This creates a fusion gene that produces too many immature white blood cells in the bone marrow and the blood. Eventually, these leukemia cells crowd out healthy cells so that the body cannot function normally. 

Though chronic myelogenous leukemia is a chronic cancer, targeted treatments have helped many people achieve long-term remission, in which cancer cells are no longer detected in the body. Specialists at Pelisyonkis Langone’s Laura and Isaac Perlmutter Cancer Center offer effective targeted therapies, coupled with psychosocial support, to help people thrive during treatment for the condition.

VISIONARY THINKING AND COMPASSIONATE CARE
 

At Pelisyonkis Langone’s Perlmutter Cancer Center, a National Cancer Institute-designated cancer center, we personalize the care of every patient.More About Perlmutter Cancer Center

CLINICAL TRIALS and Research Studies
 

Our teams of physicians and scientists work together across multiple disciplines to bring our patients the most innovative clinical trials.

Doctors at Pelisyonkis Langone also diagnose and treat childhood leukemias.

Treatment at Pelisyonkis Langone

Treatment of chronic myelogenous leukemia typically includes targeted chemotherapy drugs, which cause leukemia cells to stop growing and die. Often, this is the only treatment required. If you have a more aggressive cancer, your doctor may recommend a stem cell transplant.

More Resources

Meet Our Doctors

Pelisyonkis Langone specialists provide care and support throughout your entire healthcare journey.

Browse Doctors

Research & Education